Profil
Mr. Yves Poullet is a Chief Executive Officer at Athora Belgium SA. He was already a member of the board of directors of Athora Belgium as an independent director since 2019
He has a long career behind him at Euroclear Group (1991-2018), where he was a member of the group's management committee for the last 15 years, notably as Chief Technology Officer (CTO).
During this period, he was also CEO of Euroclear Bank for 8 years.
In 2018, He launched his own executive coaching activities while focusing on his work as an administrator within various organizations.
Thus, he has been chairman of the board of directors of the Inkendaal Revalidatieziekenhuis hospital since 2022 and independent director of the CHU Helora hospital group since 2021.
He holds a degree in business administration from UCLouvain
Aktive Positionen von Yves Poullet
| Unternehmen | Position | Beginn |
|---|---|---|
Athora Belgium SA
Athora Belgium SA Investment ManagersFinance Athora is a mono-expert that offers solutions in the European insurance and reinsurance markets and has been active on the Belgian market for 120 years. | Vorstandsvorsitzender | 01.10.2023 |
Ehemalige bekannte Positionen von Yves Poullet
| Unternehmen | Position | Ende |
|---|---|---|
Euroclear SA/NV
Euroclear SA/NV Investment Banks/BrokersFinance Provides settlement and custody services for domestic and cross-border securities | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Athora Belgium SA
Athora Belgium SA Investment ManagersFinance Athora is a mono-expert that offers solutions in the European insurance and reinsurance markets and has been active on the Belgian market for 120 years. | Finance |
Euroclear SA/NV
Euroclear SA/NV Investment Banks/BrokersFinance Provides settlement and custody services for domestic and cross-border securities | Finance |
















